Cardiovascular Disease Risk in HIV Patients Completed Phase 1 / 2 Trials for Acetylsalicylic acid (DB00945)

IndicationStatusPhase
DBCOND0075863 (Cardiovascular Disease Risk in HIV Patients)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02401269Cardiovascular Risk in HIV Patients on Antiretroviral Therapy Therapy: The MHEART StudyPrevention